US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biologics Market Research Reports & Industry Analysis

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.
RSS Feeds

Biologics Industry Research & Market Reports

< prev 1    3  4  5  6  
Conference Documentation: Lyophilisation -Europe
6/30/2015 | published by: SMI Publishing, Ltd
... of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines. As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods ...  |  read more...
USD 788.78
Biopharmaceuticals Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ...  |  read more...
USD 4,000
Conference Documentation: Immunogenicity
6/30/2015 | published by: SMI Publishing, Ltd
... the latest updates on the prediction and reduction of immunogenicity, clinical results and interpetations and optimising bioassays. Led by selected case studies from leading drug developement teams, bioanalytical experts, and academics we aim to provide ...  |  read more...
USD 788.78
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2015/2016
7/10/2015 | published by: Barnett Educational Services
... the latest intelligence on every aspect of biopharmaceutical development – from product discovery, to R&D performance and productivity, to time-to-market trends. With real-world analysis and key contributions from leading consultancies and experts, the Sourcebook includes: ...  |  read more...
USD 425
North America Spine Surgery Devices Market by Product (Non-Fusion Implants, Spinal Fusion and Fixation Devices, Spine Biologics, Spine Bone Stimulators, VCFT Devices), by End User (Hospitals, Orthopedic Clinics), by Geography - Analysis and Forecast to 20
5/11/2015 | published by: MicroMarketMonitor
... market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the ...  |  read more...
USD 2,650
Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
5/18/2015 | published by: Visiongain
... will stay ahead with exclusive market data and industry knowledge, benefitting your influence. And you can explore trends, developments, results, opportunities and sales predictions. Visiongain’s new study reveals what’s possible for biological drugs – their ...  |  read more...
USD 4,648
Biologics Markets in China
6/1/2015 | published by: Asia Market Information & Development Company
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ...  |  read more...
USD 4,000
Biologicals in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... developing 2333 biological drugs in 5702 developmental projects in cancer. In addition, there are 27 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1017 drugs. Biologicals In ...  |  read more...
USD 11,025
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Europe Spine Surgery Devices Market by Product (Spinal Fusion & Fixation Devices, Spine Biologics, Non-Fusion Implants, Spine Bone Stimulators), by End-User (Orthopedic Clinics & Spine Centers, Hospitals), by Geography – Analysis & Forecast to 2019
5/20/2015 | published by: MicroMarketMonitor
... 2019 The European spine surgery devices market is expected to reach $2,993.6 million by 2019, at a CAGR of 7.3% from 2014 to 2019. This is mainly due to the increasing incidences of spinal deformities ...  |  read more...
USD 2,650
Asia Pacific Spine Surgery Devices Market by Products (Non-Fusion Implants, Spinal Fusion & Fixation Devices, Spine Biologics, Spine Bone Stimulators, Vertebral Compression Fracture Treatment Devices), by End-User, by Geography - Analysis and Forecast to
6/5/2015 | published by: MicroMarketMonitor
... as disc compression amongst the aging population in the Asia-Pacific region, and the popularity of non-fusion devices, such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement ...  |  read more...
USD 2,650
2015 Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic, and Medical Device Markets
6/17/2015 | published by: Yole Developpement
... over the next five years. THE MICROFLUIDIC INDUSTRY IS NOW WELL STRUCTURED FOR FURTHER GROWTH As a logical consequence of impressive growth for several years running, the Microfluidic Industry is showing production-strengthening signs on both ...  |  read more...
USD 6,750
Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)
8/29/2014 | published by: Kalorama Information
... stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have ...  |  read more...
USD 3,995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
2/18/2015 | published by: GlobalData
... information on and analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare ...  |  read more...
USD 1,995
Orphan Drugs (Biologics, Non-Biologics)
4/1/2015 | published by: Global Industry Analysts
... forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...  |  read more...
USD 4,950
Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), And Geography - Forecast Till 2019
2/11/2015 | published by: MarketsandMarkets
... was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to grow at a CAGR ...  |  read more...
USD 4,650
Cystic Fibrosis Market in Europe 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect ...  |  read more...
USD 3,000
European Markets For Soft Tissue Reinforcement And Regeneration
4/1/2015 | published by: iData Research, Inc.
... of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a ...  |  read more...
USD 9,995
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
2/18/2015 | published by: MarketsandMarkets
... is used to determine the presence of bacterial toxins in pharmaceutical, biotechnology, and medical device products, intended for medical or veterinary use. Spot checks of all batches of pharmaceutical, biotechnology, and medical device products are ...  |  read more...
USD 4,650
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
2/18/2015 | published by: GlobalData
... of information on and analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and ...  |  read more...
USD 1,995
Biopharmaceuticals (Recombinant Protein, Monoclonal Antibodies, Insulin, and Vaccines)
5/1/2015 | published by: Global Industry Analysts
... separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these ...  |  read more...
USD 4,950
Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019
5/1/2015 | published by: MarketsandMarkets
... market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies ...  |  read more...
USD 5,650
Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 20
4/27/2015 | published by: MarketsandMarkets
... safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. Over the years, the ...  |  read more...
USD 4,650
Conference Documentation: Lyophilisation USA
4/30/2015 | published by: SMI Publishing, Ltd
... the pharmaceutical industry. This is contributing to the projected rise in investment, currently dominated by North America, which is expected to reach $4.80 billion in 2020. This rate of growth is a result of new ...  |  read more...
USD 788.78
The 2016-2021 World Outlook for Biologics for Veterinary, Industrial, and Other Uses
4/6/2015 | published by: Icon Group International, Inc.
... year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of ...  |  read more...
USD 995
< prev 1    3  4  5  6